MAIDENHEAD, England, Sept. 30, 2019 /PRNewswire/ -- Johnson & Johnson Ltd. has announced the appointment of Carlton Lawson as Area Managing Director Northern Europe, effective 1 September 2019. Lawson will oversee the management of the Northern Europe Consumer business and acceleration of growth across the cluster which includes the United Kingdom, Ireland, Norway, Sweden, Denmark and Finland.
He joins the EMEA Consumer Leadership team responsible for delivering innovation and excellence across the region's portfolio of iconic brands including JOHNSON'S® Baby, LISTERINE® and NEUTROGENA®.
Lawson brings with him over 25 years' experience in the healthcare industry. He most recently served as Head of Global Categories at GSK leading the global marketing team for GSK's Consumer Healthcare brand portfolio. He was also responsible for significant transformation programmes across the business, including the integration of Novartis in Northern Europe.
Prior to GSK, Lawson held roles at Johnson & Johnson where he led the global Pain, Digestive Health, Cough/Cold and Allergy franchises.
Commenting on the appointment, Pat Smallcombe, Company Group Chairman Consumer EMEA, Johnson & Johnson, said: "We're delighted to welcome Carlton back to the Johnson & Johnson Family of Consumer Companies. His exceptional knowledge of the industry paired with his track record of delivering results make him an excellent leader for our Northern Europe business and valued member of our global leadership team".
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
SOURCE Johnson & Johnson Ltd.